Obstacles to the adoption of personalized medicine – technological characteristics
| Obstacles – technological characteristics | Description |
|---|---|
| Physicians’ culture and skills | The “doctor” plays a central role in health. With PM, this role changes, and the patient become more active. Other skills are needed; medical school curricula will have to be revised |
| Patients’ lack of knowledge | The patient is uninformed about the potential and reality of PM. They should have a more active role in the future. Patients must be able to give their opinion on new treatments. It is necessary for the patient to clarify his/her lack of knowledge and for the doctor to listen |
| Clinical protocols | There are few current clinical protocols involving PM |
| Typology of diseases | The typology of diseases will change Many diseases should be restructured and reclassified, as well as ICD |
| Research funding | Research in MP is expensive, and there is a lack of resources for this purpose, either because of government crises, due to the lack of knowledge, or lack of strategy of the funding agencies |
| Limits of the new technology | Some oncology drugs have not yet been identified for some types of tumor Advances in mental illness are below expectations |
| Obstacles – technological characteristics | Description |
|---|---|
| Physicians’ culture and skills | The “doctor” plays a central role in health. With PM, this role changes, and the patient become more active. Other skills are needed; medical school curricula will have to be revised |
| Patients’ lack of knowledge | The patient is uninformed about the potential and reality of PM. They should have a more active role in the future. Patients must be able to give their opinion on new treatments. It is necessary for the patient to clarify his/her lack of knowledge and for the doctor to listen |
| Clinical protocols | There are few current clinical protocols involving PM |
| Typology of diseases | The typology of diseases will change |
| Research funding | Research in MP is expensive, and there is a lack of resources for this purpose, either because of government crises, due to the lack of knowledge, or lack of strategy of the funding agencies |
| Limits of the new technology | Some oncology drugs have not yet been identified for some types of tumor |